Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell ...

Rival companies trying to develop oral weight-loss candidates include Novo Nordisk, which has an oral formulation of ...

Pharma has so far been exempted from Trump's tariff blitz, which imposed a flat rate of 10% on imports from 5th April and ...

The Advisory Committee on Immunisation Practices (ACIP) has voted to widen the recommendations on the use of RSV shots to ...

A complaint against GSK accusing it of a major breach of the pharma industry's code of practice on prescribing information ...

The South San Francisco biotech has acquired rights to tralesinidase alfa, an enzyme replacement therapy (ERT) for the ...

Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.

The EU approval comes after Eisai and Biogen were given approval for a new once-monthly intravenous maintenance dose of ...

The concerns were first raised in The Guardian, which highlighted that one in five requests to access the data is from ...

By leveraging data, digitalisation, and artificial intelligence (AI), the network aims to transform its operations, making ...

Recorded onsite at The Eden Project in Cornwall, the conversation centred around the Adelphi Group-sponsored panel, ‘The ...

Theravia made more than €50 million in revenues in 2024 and has seen its sales rise by an annual rate of around 10% in recent ...